Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$987M |
| 2 |
Salesforce
CRM
|
+$660M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$586M |
| 4 |
HCA Healthcare
HCA
|
+$513M |
| 5 |
Netflix
NFLX
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$815M |
| 2 |
Incyte
INCY
|
+$811M |
| 3 |
NVIDIA
NVDA
|
+$514M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$493M |
| 5 |
MetLife
MET
|
+$366M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.63% |
| 2 | Technology | 14.62% |
| 3 | Industrials | 7.95% |
| 4 | Healthcare | 7.93% |
| 5 | Energy | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BANX
5401
ArrowMark Financial
BANX
$202M
| $79K | ﹤0.01% |
4,731
+450
| +11% | +$7.62K |
|
5402
Central Pacific Financial
CPF
$996M
| $79K | ﹤0.01% |
4,980
-9,122
| -65% | -$144K |
|
5403
iShares MSCI Spain ETF
EWP
$2.22B
| $79K | ﹤0.01% |
2,719
-38,002
| -93% | -$1.07M |
|
|
FSP
5404
Franklin Street Properties
FSP
$50.8M
| $79K | ﹤0.01% |
54,070
-7,685
| -12% | -$10.6K |
|
|
GPMT
5405
Granite Point Mortgage Trust
GPMT
$57.4M
| $79K | ﹤0.01% |
15,015
-9,163
| -38% | -$43.5K |
|
5406
MiMedx Group
MDXG
$622M
| $79K | ﹤0.01% |
11,882
+5,515
| +87% | +$28.1K |
|
|
PRPH
5407
DELISTED
ProPhase Labs
PRPH
| $79K | ﹤0.01% |
1,088
+1,040
| +2,167% | +$84.6K |
|
5408
Repay Holdings
RPAY
$329M
| $79K | ﹤0.01% |
10,193
+3,539
| +53% | +$23.8K |
|
5409
TETRA Technologies
TTI
$1.27B
| $79K | ﹤0.01% |
23,370
+6,588
| +39% | +$19.1K |
|
5410
VirTra
VTSI
$36.6M
| $79K | ﹤0.01% |
+10,483
| New | +$70K |
|
|
PWRD
5411
TCW Transform Systems ETF
PWRD
$1.53B
| $79K | ﹤0.01% |
+1,505
| New | +$74.7K |
|
|
VNMC
5412
DELISTED
Natixis Vaughan Nelson Mid Cap ETF
VNMC
| $79K | ﹤0.01% |
2,657
-6
| -0.2% | -$173 |
|
5413
Cato Corp
CATO
$67.9M
| $78K | ﹤0.01% |
9,764
-3,980
| -29% | -$33K |
|
|
CWEN.A
5414
DELISTED
Clearway Energy Class A
CWEN.A
| $78K | ﹤0.01% |
2,926
-15,496
| -84% | -$449K |
|
5415
Ginkgo Bioworks
DNA
$457M
| $78K | ﹤0.01% |
1,037
+493
| +91% | +$29.2K |
|
5416
Fidelity Momentum Factor ETF
FDMO
$940M
| $78K | ﹤0.01% |
1,617
-11,416
| -88% | -$524K |
|
5417
Heart Test Laboratories
HSCS
$8.03M
| $78K | ﹤0.01% |
860
| – | – |
|
5418
Invesco KBW Premium Yield Equity REIT ETF
KBWY
$309M
| $78K | ﹤0.01% |
4,318
-372
| -8% | -$6.46K |
|
5419
ProKidney
PROK
$278M
| $78K | ﹤0.01% |
6,965
+5,860
| +530% | +$62.4K |
|
5420
SmartRent
SMRT
$286M
| $78K | ﹤0.01% |
20,231
+10,020
| +98% | +$30.6K |
|
5421
SoundThinking
SSTI
$81.6M
| $78K | ﹤0.01% |
3,598
+92
| +3% | +$2.41K |
|
5422
iShares MSCI Thailand ETF
THD
$353M
| $78K | ﹤0.01% |
1,181
-8
| -0.7% | -$560 |
|
|
CANO
5423
DELISTED
Cano Health, Inc.
CANO
| $78K | ﹤0.01% |
560
+251
| +81% | +$32.2K |
|
5424
Green Plains
GPRE
$1.09B
| $77K | ﹤0.01% |
2,400
-874
| -27% | -$27.7K |
|
5425
IHS Holding
IHS
$2.82B
| $77K | ﹤0.01% |
7,870
-46
| -0.6% | -$404 |
|
Similar funds
Royal Bank of Canada's Q2 2023 Portfolio in Review
As of Q2 2023, Royal Bank of Canada held 8,037 positions worth $381B, up 7.7% from $354B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Royal Bank of Canada's Q2 2023 filing shows 675 new, 3,796 increased, 2,511 reduced and 409 closed positions. Its largest new stake was ATS Corp: 3,088,815 shares worth $142M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $815M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Technology and Industrials.
- Royal Bank of Canada's largest Q2 2023 buy was ATS Corp: 3,088,815 shares worth $142M.
- Royal Bank of Canada added most to Thermo Fisher Scientific in Q2 2023, an estimated $987M increase.
- Royal Bank of Canada's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $815M.
- Royal Bank of Canada fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $150M.
- Royal Bank of Canada's ten largest holdings make up 19% of its $381B portfolio in Q2 2023.
- Royal Bank of Canada opened 675 new positions and closed 409 in Q2 2023.
- Royal Bank of Canada's portfolio value rose 7.7% quarter-over-quarter to $381B.
Based on Royal Bank of Canada's 13F filing for Q2 2023, filed 14 Aug 2023.